Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/23/2026

Imaging Strategy for Hydronephrosis: Contrast‑Enhanced CT Urography vs. Non‑Contrast CT

Indications for Contrast‑Enhanced CT Urography (CTU)

  • The American College of Radiology recommends that when hydronephrosis has already been identified but the underlying cause remains unknown, clinicians should proceed directly to contrast‑enhanced CT urography (CTU) rather than a non‑contrast study, because CTU provides superior diagnostic accuracy for determining etiology. 1
  • In the diagnostic algorithm, patients with known hydronephrosis of uncertain origin should be imaged with contrast‑enhanced CT (CTU) to identify the obstructive lesion. 1
  • If a non‑contrast CT excludes calculi but hydronephrosis persists, the ACR advises obtaining contrast‑enhanced images (or proceeding to CTU/MR urography) to evaluate non‑calculous causes. 1

Indications for Non‑Contrast CT

  • For patients in whom obstructive urolithiasis is the primary suspected cause, the ACR states that a non‑contrast CT of the abdomen and pelvis is appropriate and sufficient. 2
  • Non‑contrast CT is the preferred imaging modality for patients presenting with renal colic and moderate‑to‑severe hydronephrosis on ultrasound, as these individuals have a higher risk of stone‑passage failure. 2
  • In the clinical decision pathway, flank‑pain presentations with suspected stone disease should be evaluated with non‑contrast CT. 2

Imaging for Suspected Infection (Pyonephrosis)

  • When infection with obstruction is suspected, the ACR recommends contrast‑enhanced CT to differentiate pyonephrosis from simple hydronephrosis. 2
  • In cases of suspected pyonephrosis, a collecting‑system attenuation > 9.75 HU on CT may suggest infection, although contrast‑enhanced CT can still have difficulty distinguishing infected from non‑infected hydronephrosis. 2
  • Recent administration of iodinated contrast can falsely raise collecting‑system attenuation, potentially mimicking pyonephrosis; clinicians should interpret high HU values with caution. 2

Diagnostic Approach to Hydronephrosis of Unknown Cause

Introduction to Diagnostic Guidelines

  • The American College of Radiology guidelines state that renal ultrasound is less useful for identification of the etiology of hydronephrosis when CT has already excluded obstructing stones 3
  • Ultrasound cannot reliably determine the cause of hydronephrosis when CT has already excluded obstructing stones 3
  • The American College of Radiology recommends that when hydronephrosis of unknown cause is identified, more comprehensive evaluation with CT, MRU, or renal scintigraphy is needed rather than additional ultrasound 3, 4
  • The American College of Radiology recommends CT urography (CTU) with contrast or MR urography (MRU) as the next step in evaluating hydronephrosis of unknown cause, depending on renal function and clinical context 4, 5, 6
  • CTU provides near-comprehensive evaluation of the genitourinary tract, including both morphological and functional information 5, 6
  • MRU is preferred over CTU in patients with renal impairment due to contrast concerns 7

Clinical Algorithm

  • Assess renal function, and if normal, proceed with CTU with IV contrast 3, 5, 6
  • If renal function is impaired, proceed with MRU without and with IV contrast 7
  • Consider renal scintigraphy if functional assessment of obstruction severity is needed beyond anatomical imaging 3, 4
  • Skip repeat ultrasound as it will not change management or provide the etiologic information needed 3, 4

Important Considerations

  • The presence of hydronephrosis on ultrasound reduces the likelihood of finding alternative diagnoses, meaning if CT already showed hydronephrosis, ultrasound won't reveal unexpected pathology 8, 9
  • Do not delay definitive imaging (CTU or MRU) by ordering intermediate studies like ultrasound when the goal is to identify the cause of unexplained hydronephrosis 3, 4